Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges
4.3 Opportunities


5. China Vaccine Market

5.1 Public
5.2 Private


6. China Vaccine Doses

6.1 Public
6.2 Private


7. China Vaccine Share Analysis

7.1 By Sectors Market Share
7.2 By Sectors Vaccine Doses Share
7.3 By Products Type Market Share
7.4 By Disease Type Market Share


8. Meningococcal Meningitis Vaccine Market & Doses Analysis

8.1 Meningococcal Meningitis Vaccine

8.1.1 Public
8.1.2 Private

8.2 Meningococcal Meningitis Doses

8.2.1 Public
8.2.2 Private


9. Pneumococcal Vaccines Market & Doses Analysis

9.1 Pneumococcal Vaccines
9.2 Pneumococcal Vaccines Doses


10. DTP Vaccine Market & Doses Analysis

10.1 DTP Vaccine Market

10.1.1 DTaP
10.1.2 DTcP

10.2 DTP Vaccine Doses

10.2.1 Public
10.2.2 Private


11. Rabies Vaccine Market


12. Ebola Vaccine Market


13. Product - China Vaccine Market

13.1 MCV4
13.2 MPSV4
13.3 MCV2-Hib
13.4 MCV2
13.5 MPSV2 and Men A
13.6 PCV13
13.7 PPV23
13.8 Others


14. The Vaccine Regulatory Authority of China


15. Required and Recommended Vaccinations for China Travel


16. Mergers & Acquisitions


17. Company Sales

17.1 Sinopharm Group (China National Biotec Group Company Limited)

17.1.1 Overview
17.1.2 Recent Initiatives
17.1.3 Net Sales

17.2 Hualan Biological Engineering Inc

17.2.1 Overview
17.2.2 Recent Initiatives
17.2.3 Net Sales

17.3 Chongqing Zhifei Biological Products Co Ltd

17.3.1 Overview
17.3.2 Recent Initiatives
17.3.3 Net Sales

17.4 Walvax Biotechnology Co Ltd

17.4.1 Overview
17.4.2 Recent Initiatives
17.4.3 Net Sales

17.5 Beijing Tiantan Biological Products Corp Ltd

17.5.1 Overview
17.5.2 Recent Initiatives
17.5.3 Net Sales

17.6 Sinovac Biotech

17.6.1 Overview
17.6.2 Recent Initiatives
17.6.3 Net Sales

17.7 Shenzhen Kangtai Biological Products Co Ltd

17.7.1 Overview
17.7.2 Recent Initiatives
17.7.3 Net Sales



List of Figures

Figure-01: China – Public Vaccine Market (Million US$), 2017 – 2022
Figure-02: China – Forecast for Public Vaccine Market (Million US$), 2023 – 2027
Figure-03: China – Private Vaccine Market (Million US$), 2017 – 2022
Figure-04: China – Forecast for Private Vaccine Market (Million US$), 2023 – 2027
Figure-05: China – Public Vaccine Doses (Million), 2017 – 2022
Figure-06: China – Forecast for Public Vaccine Doses (Million), 2023 – 2027
Figure-07: China – Private Vaccine Doses (Million), 2017 – 2022
Figure-08: China – Forecast for Private Vaccine Doses (Million), 2023 – 2027
Figure-09: Public – Meningococcal Meningitis Vaccine Market (Million US$), 2017 – 2022
Figure-10: Public – Forecast for Meningococcal Meningitis Vaccine Market (Million US$), 2023 – 2027
Figure-11: Private – Meningococcal Meningitis Vaccine Market (Million US$), 2017 – 2022
Figure-12: Private – Forecast for Meningococcal Meningitis Vaccine Market (Million US$), 2023 – 2027
Figure-13: Public – Meningococcal Meningitis Vaccine Doses (Million), 2017 – 2022
Figure-14: Public – Forecast for Meningococcal Meningitis Vaccine Doses (Million), 2023 – 2027
Figure-15: Private – Meningococcal Meningitis Vaccine Doses (Million), 2017 – 2022
Figure-16: Private – Forecast for Meningococcal Meningitis Vaccine Doses (Million), 2023 – 2027
Figure-17: China – Pneumococcal Vaccines Market (Million US$), 2017 – 2022
Figure-18: China – Forecast for Pneumococcal Vaccines Market (Million US$), 2023 – 2027
Figure-19: China – Pneumococcal Vaccines Doses Doses (Million), 2017 – 2022
Figure-20: China – Forecast for Pneumococcal Vaccines Doses Doses (Million), 2023 – 2027
Figure-21: China – DTP Vaccine Market (Million US$), 2017 – 2022
Figure-22: China – Forecast for DTP Vaccine Market (Million US$), 2023 – 2027
Figure-23: China – DTaP Vaccine Market Market (Million US$), 2017 – 2022
Figure-24: China – Forecast for DTaP Vaccine Market Market (Million US$), 2023 – 2027
Figure-25: China – DTcP Vaccine Market Market (Million US$), 2017 – 2022
Figure-26: China – Forecast for DTcP Vaccine Market Market (Million US$), 2023 – 2027
Figure-27: DTP – Public Vaccine Doses (Million), 2017 – 2022
Figure-28: DTP – Forecast for Public Vaccine Doses (Million), 2023 – 2027
Figure-29: DTP – Private Vaccine Doses (Million), 2017 – 2022
Figure-30: DTP – Forecast for Private Vaccine Doses (Million), 2023 – 2027
Figure-31: China – Rabies Vaccine Market (Million US$), 2017 – 2022
Figure-32: China – Forecast for Rabies Vaccine Market (Million US$), 2023 – 2027
Figure-33: China – Ebola Vaccine Market (Million US$), 2018 – 2022
Figure-34: China – Forecast for Ebola Vaccine Market (Million US$), 2023 – 2027
Figure-35: Product – MCV4 Vaccine Market (Million US$), 2020 – 2022
Figure-36: Product – Forecast for MCV4 Vaccine Market (Million US$), 2023 – 2027
Figure-37: Product – MPSV4 Vaccine Market (Million US$), 2017 – 2022
Figure-38: Product – Forecast for MPSV4 Vaccine Market (Million US$), 2023 – 2027
Figure-39: Product – MCV2-Hib Vaccine Market (Million US$), 2017 – 2022
Figure-40: Product – Forecast for MCV2-Hib Vaccine Market (Million US$), 2023 – 2027
Figure-41: Product – MCV2 Vaccine Market (Million US$), 2017 – 2022
Figure-42: Product – Forecast for MCV2 Vaccine Market (Million US$), 2023 – 2027
Figure-43: Product – MPSV2 and Men A Vaccine Market (Million US$), 2017 – 2022
Figure-44: Product – Forecast for MPSV2 and Men A Vaccine Market (Million US$), 2023 – 2027
Figure-45: Product – PCV13 Vaccine Market (Million US$), 2017 – 2022
Figure-46: Product – Forecast for PCV13 Vaccine Market (Million US$), 2023 – 2027
Figure-47: Product – PPV23 Vaccine Market (Million US$), 2017 – 2022
Figure-48: Product – Forecast for PPV23 Vaccine Market (Million US$), 2023 – 2027
Figure-49: Product – Others Vaccine Market (Million US$), 2017 – 2022
Figure-50: Product – Forecast for Others Vaccine Market (Million US$), 2023 – 2027
Figure-51: Sinopharm Group (China National Biotec Group Company Limited) – Global Revenue (Billion US$), 2017 – 2022
Figure-52: Sinopharm Group (China National Biotec Group Company Limited) – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-53: Hualan Biological Engineering Inc – Global Revenue (Million US$), 2017 – 2022
Figure-54: Hualan Biological Engineering Inc – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-55: Chongqing Zhifei Biological Products Co Ltd – Global Revenue (Million US$), 2017 – 2022
Figure-56: Chongqing Zhifei Biological Products Co Ltd – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-57: Walvax Biotechnology Co Ltd – Global Revenue (Million US$), 2017 – 2022
Figure-58: Walvax Biotechnology Co Ltd – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-59: Beijing Tiantan Biological Products Corp Ltd – Global Revenue (Million US$), 2017 – 2022
Figure-60: Beijing Tiantan Biological Products Corp Ltd – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-61: Sinovac Biotech – Global Revenue (Million US$), 2017 – 2022
Figure-62: Sinovac Biotech – Forecast for Global Revenue (Million US$), 2023 – 2027
Figure-63: Shenzhen Kangtai Biological Products Co Ltd – Global Revenue (Million US$), 2017 – 2022
Figure-64: Shenzhen Kangtai Biological Products Co Ltd – Forecast for Global Revenue (Million US$), 2023 – 2027

List of Tables

Table-01: China – Vaccine Market Share by Sectors (Percent), 2017 – 2021
Table-02: China – Forecast for Vaccine Market Share by Sectors (Percent), 2022 – 2027
Table-03: China – Vaccine Doses Share by Sectors (Percent), 2017 – 2021
Table-04: China – Forecast for Vaccine Doses Share by Sectors (Percent), 2022 – 2027
Table-05: China – Vaccine Market Share by Products Type (Percent), 2017 – 2021
Table-06: China – Forecast for Vaccine Market Share by Products Type (Percent), 2022 – 2027
Table-07: China – Vaccine Market Share by Disease Type (Percent), 2017 – 2021
Table-08: China – Forecast for Vaccine Market Share by Disease Type (Percent), 2022 – 2027